Eliem Therapeutics (ELYM) SEC Filings & 10K Form → Who are Nvidia’s New Silent Partners? (From Weiss Ratings) (Ad) Free ELYM Stock Alerts $7.66 +0.25 (+3.37%) (As of 05/28/2024 ET) Add Compare Share Share SEC FilingsStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrendsStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends Recent Eliem Therapeutics SEC Filings All Filing Types 1 10 10-D 10-K 10-M 10-Q 11-K 12b-25 13F 13H 144 15 15F 17-H 18 18-K 19b-4(e) 19b-4 19b-7 1-A 1-E 1-K 1-N 1-SA 1-U 1-Z 20-F 24F-2 25 2-E 3 4 40-F 5 6-K 7-M 8-A 8-K 8-M 9-M ABS DD-15E ABS-15G ABS-EE ADV ADV-E ADV-H ADV-NR ADV-W ATS ATS-R BD BD-N BDW C CA-1 CB CFPORTAL D F-1 F-10 F-3 F-4 F-6 F-7 F-8 F-80 F-N F-X ID MA MA-I MA-NR MA-W MSD MSDW n/a N-14 N-17D-1 N-17f-1 N-17f-2 N-18f-1 N-1A N-2 N-23c-3 N-27D-1 N-3 N-4 N-5 N-54A N-54C N-6 N-6EI-1 N-6F N-8A N-8B-2 N-8B-4 N-8F N-CR N-CSR N-MFP N-PX N-Q NRSRO N-SAR PF PILOT R31 S-1 S-11 S-20 S-3 S-4 S-6 S-8 SBSE SBSE-A SBSE-BD SBSE-C SBSE-W SCI SD SDR SE SF-1 SF-3 SIP T-1 T-2 T-3 T-4 T-6 TA-1 TA-2 TA-W TCR TH WB-APP X-17A-19 X-17A-5 Part I X-17A-5 Part II X-17A-5 Part IIA X-17A-5 Part IIB X-17A-5 Part III X-17A-5 Schedule I X-17F-1A Filing Types Include Ownership Filings Exclude Ownership Filings Only Show Ownership FIlings Ownership Filings Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel DateFilerForm TypeView05/15/20245:19 AMEliem Therapeutics (Filer)Form 10-QGeneral form for quarterly reports under Section 13 or 15(d) 05/07/20245:01 PMAffinity Asset Advisors, LLC (Filed by)Eliem Therapeutics (Subject)Form SC 13G04/12/20245:52 PMEliem Therapeutics (Subject)RA CAPITAL MANAGEMENT, L.P. (Filed by)Form SC 13D/A04/11/20247:01 AMEliem Therapeutics (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 04/11/20247:10 AMEliem Therapeutics (Filer)Form DEFA14A04/08/20244:33 PMEliem Therapeutics (Issuer)Morisset Valerie (Reporting)Form 4Statement of changes in beneficial ownership of securities 03/28/20243:05 PMEliem Therapeutics (Filer)Form 10-KAnnual report pursuant to Section 13 or 15(d) 03/20/20243:33 PMEliem Therapeutics (Issuer)Pimblett Emily (Reporting)Form 4Statement of changes in beneficial ownership of securities 03/04/202410:07 AMEliem Therapeutics (Issuer)Morisset Valerie (Reporting)Form 4Statement of changes in beneficial ownership of securities 02/07/202410:53 AMBML Investment Partners, L.P. (Filed by)Eliem Therapeutics (Subject)Form SC 13G/A11/17/20233:30 PMEliem Therapeutics (Subject)RA CAPITAL MANAGEMENT, L.P. (Filed by)Form SC 13D/A11/14/20233:01 PMEliem Therapeutics (Filer)Form 10-QGeneral form for quarterly reports under Section 13 or 15(d) 11/13/20234:13 PMAI ETI LLC (Filed by)Eliem Therapeutics (Subject)Form SC 13D/A07/20/20235:55 AMEliem Therapeutics (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) (Data available from 1/1/2016 forward) Related Companies and Tools Related Companies: CGEN SEC Filings XBIT SEC Filings CUE SEC Filings MRNS SEC Filings BIOR SEC Filings MEIP SEC Filings CMPS SEC Filings ALT SEC Filings IMNM SEC Filings IRON SEC Filings SEC Filings Tools: Latest SEC FilingsInsider Trading Activity This page (NASDAQ:ELYM) was last updated on 5/28/2024 by MarketBeat.com Staff From Our PartnersRevealed: The Unknown Biotech Powering AI in HealthcareBehind the MarketsThe #1 Crypto That You Don’t Own… YetCrypto 101 MediaWARNING about the death of the U.S. dollar…Colonial MetalsDigitizing the $11T commodities sector with one tiny stockResource Stock DigestTim Sykes’ Urgent Trade Alert: “Make this move now”Timothy SykesBiggest Prediction of My 50-Year Career on Wall StreetChaikin AnalyticsElon’s New Device is About to Shock the WorldInvestorPlaceHe Is Giving Away BitcoinCrypto Swap Profits Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Eliem Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
